United States & Merck & Co.
12 shared events · Importance 6 · Last updated Jun 11, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Accidents
United States: United States>>> has bolstered precautions, including screening air passengers and suspending visa services, and has provided $13 million in assistance for the response.
Merck & Co.: Merck & Co. is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
Business
United States: The United States equities market experienced overall gains across major indices, indicating a generally positive economic environment.
Merck & Co.: Merck & Co. saw its stock price rise, contributing to the gains in the Dow Jones Industrial Average.
May 20, 2026 · 12 articles
Tech
United States: The studies discussed involve patients and practices within the United States>>> and address a significant health concern for American women.
Merck & Co.: Merck & Co.>>>'s immunotherapy Keytruda is mentioned as potentially faring better when patients are also taking GLP-1 drugs, suggesting a possible interaction with the immune system.
Jun 02, 2026 · 37 articles
Accidents
United States: The United States>>> has pledged financial aid and is monitoring the Ebola outbreak, with some of its citizens exposed or infected, but its previous aid cuts and withdrawal from the World Health Organization>>> have been criticized for weakening global health response capacity.
Merck & Co.: Merck & Co.>>>'s Ervebo vaccine, effective against the Zaire strain of Ebola, is being considered for potential use against the Uganda — Bundibugyo strain, though its efficacy is still under assessment.
May 18, 2026 · 505 articles
Domestic
United States: The United States' stock markets showed mixed to positive performance, and its negotiations with Iran impacted crude oil prices.
Merck & Co.: Merck & Co. posted strong gains, contributing to the positive performance of Dow components.
May 28, 2026 · 6 articles
Tech
United States: United States>>> is one of the countries where patients were enrolled for the KEYNOTE-942 trial, contributing to the global scope of the research. Its involvement highlights its participation in international medical studies and its significant burden of skin cancer cases.
Merck & Co.: As the manufacturer of pembrolizumab (Keytruda), Merck & Co.>>> benefits from the combination therapy's success, as it reinforces the drug's role as a standard of care and expands its potential market in combination with intismeran. The positive results could lead to continued strong sales for pembrolizumab.
Jun 01, 2026 · 6 articles
Domestic
Merck & Co.: Merck & Co., a hepatitis B vaccine maker, expressed deep concern over the ACIP's vote, and its shares closed down 1.2% on Friday.
Dec 05, 2025 · 7 articles
Regulatory
Merck & Co.: Merck & Co. struck a deal to cut prices, committing to sell its diabetes drugs Januvia, Janumet, and Janumet XR at 70% off list prices directly to US consumers and pledging $70 billion in US R&D and manufacturing investments.
Dec 19, 2025 · 7 articles
NEWSDESK
Explore this relationship live
Track how United States and Merck & Co. interact across events, view sentiment trends, and discover connected entities.
Open Dashboard